PATENTS RELATED TO MYCOPLASMA

Although Dr. Demchick also represents patent seekers with non-microbiological inventions, his doctorate is in microbiology. Microbiology has been the primary focus of his research and teaching. He especially loves dealing with patent searches and applications for involving microbiology.

Dr. Demchick is a scientist with a quarter of a century of research experience in academic, industrial and governmental settings.

If you are considering patent protection for an invention, Dr. Demchick will be glad to discuss the matter with you. There is no charge for an initial discussion.

The following sampling is to give you some sense of the types of mycoplasma related inventions which have received United States patent protection. The patent list is not exhaustive and is certainly not a substitute for a proper patent search . It should be noted that only U.S. Patents are included.

It should be noted that spelling, form and typographical errors in the original patents are preserved here.

Prevention and treatment of mycoplasma-associated diseases (United States Patent 7,108,851)

Antigen composition against mycoplasma (United States Patent 7,074,894)

Mycoplasma hyopneumoniae vaccine and methods for reducing Mycoplasma bovis pneumonia in cattle (United States Patent 7,056,492)

Mycoplasma hyopneumoniae bacterin vaccine (United States Patent 7,018,638)

One dose vaccination with Mycoplasma hyopneumoniae (United States Patent 6,846,477)

Detection of Mycoplasma in patients with chronic fatigue syndrome and related disorders (United States Patent 6,815,161)

Method for the preservation of viruses and mycoplasma (United States Patent 6,664,099)

Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae (United States Patent 6,585,981)

Multivalent Mycoplasma bacterin (United States Patent 6,548,069)

Nucleotide sequence of the mycoplasma genitalium genome, fragments thereof, and uses thereof (United States Patent 6,537,773)

Polynucleotides encoding a mycoplasma protein involved in cell growth regulation (United States Patent 6,506,892)

Detection of Mycoplasma genus and species in patients with chronic fatigue syndrome and fibromyalgia (United States Patent 6,492,113)

Nucleic acid probes for the detection of genital mycoplasmas (United States Patent 6,482,589)

Compositions comprising equisetum and symphytum and methods for the treatment of symptoms associated with mycoplasma infection (United States Patent 6,416,792)

Amplification and detection of mycoplasma pneumoniae targeting the ORF9 region of the hmw gene cluster (United States Patent 6,399,309)

Glycoglycerophospholipid, antibody thereagainst, and method for detecting mycoplasma (United States Patent 6,376,203)

Amplification and detection of mycoplasma pneumoniae targeting the P1 gene (United States Patent 6,277,582)

Mycoplasma recombinant polypeptides and vaccines (United States Patent 6,171,589)

Recombinant mycoplasma hyopneumoniae vaccine (United States Patent 6,162,435)

Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same (United States Patent 6,132,713)

Primers and probes for the amplification, detection and typing of Mycoplasma pneumoniae (United States Patent 6,110,681)

Non-virulent Mycoplasma synoviae and vaccine thereof (United States Patent 6,001,348)

Glycoglycerophospholipid, antibody thereagainst, and method for detecting mycoplasma (United States Patent 5,994,090)

Nucleic acid hybridization assay probes, helper probes and amplification oligonucleotides targeted to mycoplasma pneumoniae nucleic acid (United States Patent 5,969,122)

Arginine deiminase derived from Mycoplasma arthritidis and polymer conjugates containing the same (United States Patent 5,916,793)

Process for the decontamination of cell cultures containing mycoplasmas (United States Patent 5,902,740)

Mycoplasma arthritidis T-cell mitogen (United States Patent 5,872,233)

Recombinant Avipox virus encoding polypeptide of mycoplasma gallisepticum, and utilized a live vaccine (United States Patent 5,871,742)

Nucleic acid probes for the detection for genital mycoplasmas (United States Patent 5,843,667)

Mycoplasma expression system (United States Patent 5,821,059)

Nucleic acid primers and probes for detecting Mycoplasma pneumoniae (United States Patent 5,817,463)

Arginine deminase derived from mycoplasma arthritidis and polymer conjugates containing the same (United States Patent 5,804,183)

Mycoplasma arthritidis superantigen (United States Patent 5,795,974)

DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures (United States Patent 5,788,962)

Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same (United States Patent 5,766,594)

PCR-based assay for Mycoplasma hyopneumoniae (United States Patent 5,712,090)

Mycoplasma polymerase chain reaction testing system using a set of mixed and single sequence primers (United States Patent 5,693,467)

Nucleic acid probes and method for detecting Mycoplasma pneumoniae (United States Patent 5,691,149)

Mycoplasmas-agents for detecting and characterizing mycoplasmas in vitro (United States Patent 5,688,646)

Mycoplasmas--agents for detecting and characterizing mycoplasmas in vitro (United States Patent 5,677,123)

Nucleic acid hybridization assay probes, helper probes and amplification oligonucleotides targeted to Mycoplasma pneumoniae nucleic acid (United States Patent 5,656,427)

Monoclonal antibodies against Mycoplasma pneumoniae, hybridomas producing these, methods for the preparation thereof, and the use thereof (United States Patent 5,641,638)

Mycoplasma arthritidis T-cell mitogen (United States Patent 5,639,869)

Poultry Mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same (United States Patent 5,621,076)

Fluorometric quantitation of mycoplasmas (United States Patent 5,604,096)

Detection and prevention of mycoplasma hominis infection (United States Patent 5,595,871)

Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof (United States Patent 5,565,205)

Nucleic acid probes for the detection of mycoplasma pneumoniae and mycoplasma genitalium (United States Patent 5,552,279)

Adherent and invasive mycoplasma (United States Patent 5,534,413)

Mycoplasma diagnostic assay (United States Patent 5,532,134)

Diagnostic kit and diagnostic method for mycoplasma utilizing carbohydrate receptors (United States Patent 5,529,904)

Antibiotic compounds and methods to treat gram-positive bacterial and mycoplasmal infections (United States Patent 5,516,905)

Polynucleotide amplification mycoplasma assay, primers, and kits therefore (United States Patent 5,491,062)

Poultry mycoplasma antigen, gene thereof and recombinant vectors containing the gene as well as vaccines utilizing the same (United States Patent 5,489,430)

Arginine deiminase from a Mycoplasma arginini strain (United States Patent 5,474,928)

DNA encoding 85kd polypeptide useful in diagnosis of Mycoplasma infections in animals (United States Patent 5,459,048)

Gene encoding cytadhesin protein of mycoplasma gallisepticum and its use (United States Patent 5,378,820)

Method for detection of mycoplasma (United States Patent 5,376,525)

Method for mycoplasma detection in a biological sample (United States Patent 5,369,005)

Thimerosal inactivated mycoplasma hyopneumoniae vaccine (United States Patent 5,338,543)

Administering particular compounds against various parasites, mycoplasmas, other indications and other infections (United States Patent 5,292,725)

Methods and compositions for production of mycoplasmal adhesins (United States Patent 5,281,694)

Mycoplasma hyopneumoniae antigen and uses therefor (United States Patent 5,252,328)

Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen (United States Patent 5,242,823)

Pathogenic mycoplasma (United States Patent 5,242,820)

Intranasal administration of Mycoplasma hyopneumoniae antigen (United States Patent 5,240,706)

Adherent and invasive mycoplasma (United States Patent 5,215,914)

Method of detecting mycoplasma infection in poultry and compositions therefor (United States Patent 5,196,514)

Diagnostic methods for mycoplasma genitalium infections (United States Patent 5,158,870)

Method of preventing mycoplasma infection (United States Patent 5,104,901)

Adhesion of Mycoplasma pneumoniae and Mycoplasma hominus to sulfatide (United States Patent 5,089,479)

Method for the purification of a 168 kD protein from mycoplasma pneumoniae (United States Patent 5,084,561)

Assay for Mycoplasma fermentans (United States Patent 5,073,486)

Mycoplasma vaccine (United States Patent 5,064,647)

Prevention or elimination of mycoplasma contamination of animal or plant cell cultures (United States Patent 5,051,419)

Methods and compositions for production of mycoplasmal adhesins (United States Patent 5,026,636)

Anti-mycoplasma agent (United States Patent 4,950,686)

Monoclonal antibodies for Mycoplasma pneumoniae and use for diagnosis of pneumonia (United States Patent 4,945,041)

Method for decontamination of mycoplasma-infected cell cultures (United States Patent 4,895,803)

DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins (United States Patent 4,894,332)

Rapid detection of mycoplasmas (United States Patent 4,855,227)

Triphasic mycoplasmatales culture device (United States Patent 4,721,678)

Specific mycoplasma membrane antigen and antibody and their clinical applications (United States Patent 4,666,851)

Triphasic mycoplasmatales detection method (United States Patent 4,598,045)

Methods of controlling mycoplasma infections (United States Patent 4,594,337)

Detection of mycoplasma infection in cell cultures (United States Patent 4,387,161)

Method of using dialkylphenols in the treatment of mycoplasma diseases (United States Patent 4,192,896)

Method for the control of Mycoplasma hyopneumoniae in swine with alkylated BM123.gamma. type antibiotics (United States Patent 4,170,646)

Use of chlorhydroxyquinoline to inhibit growth of mycoplasmas (United States Patent 4,166,118)

Prevention and treatment of mycoplasma-associated diseases (United States Patent 7,108,851)

Antigen composition against mycoplasma (United States Patent 7,074,894)

Mycoplasma hyopneumoniae vaccine and methods for reducing Mycoplasma bovis pneumonia in cattle (United States Patent 7,056,492)

Mycoplasma hyopneumoniae bacterin vaccine (United States Patent 7,018,638)

One dose vaccination with Mycoplasma hyopneumoniae (United States Patent 6,846,477)

Detection of Mycoplasma in patients with chronic fatigue syndrome and related disorders (United States Patent 6,815,161)

Method for the preservation of viruses and mycoplasma (United States Patent 6,664,099)

Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae (United States Patent 6,585,981)

Multivalent Mycoplasma bacterin (United States Patent 6,548,069)

Nucleotide sequence of the mycoplasma genitalium genome, fragments thereof, and uses thereof (United States Patent 6,537,773)

Polynucleotides encoding a mycoplasma protein involved in cell growth regulation (United States Patent 6,506,892)

Detection of Mycoplasma genus and species in patients with chronic fatigue syndrome and fibromyalgia (United States Patent 6,492,113)

Nucleic acid probes for the detection of genital mycoplasmas (United States Patent 6,482,589)

Compositions comprising equisetum and symphytum and methods for the treatment of symptoms associated with mycoplasma infection (United States Patent 6,416,792)

Amplification and detection of mycoplasma pneumoniae targeting the ORF9 region of the hmw gene cluster (United States Patent 6,399,309)

Glycoglycerophospholipid, antibody thereagainst, and method for detecting mycoplasma (United States Patent 6,376,203)

Amplification and detection of mycoplasma pneumoniae targeting the P1 gene (United States Patent 6,277,582)

Mycoplasma recombinant polypeptides and vaccines (United States Patent 6,171,589)

Recombinant mycoplasma hyopneumoniae vaccine (United States Patent 6,162,435)

Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same (United States Patent 6,132,713)

Primers and probes for the amplification, detection and typing of Mycoplasma pneumoniae (United States Patent 6,110,681)

Non-virulent Mycoplasma synoviae and vaccine thereof (United States Patent 6,001,348)

Glycoglycerophospholipid, antibody thereagainst, and method for detecting mycoplasma (United States Patent 5,994,090)

Nucleic acid hybridization assay probes, helper probes and amplification oligonucleotides targeted to mycoplasma pneumoniae nucleic acid (United States Patent 5,969,122)

Arginine deiminase derived from Mycoplasma arthritidis and polymer conjugates containing the same (United States Patent 5,916,793)

Process for the decontamination of cell cultures containing mycoplasmas (United States Patent 5,902,740)

Mycoplasma arthritidis T-cell mitogen (United States Patent 5,872,233)

Recombinant Avipox virus encoding polypeptide of mycoplasma gallisepticum, and utilized a live vaccine (United States Patent 5,871,742)

Nucleic acid probes for the detection for genital mycoplasmas (United States Patent 5,843,667)

Mycoplasma expression system (United States Patent 5,821,059)

Nucleic acid primers and probes for detecting Mycoplasma pneumoniae (United States Patent 5,817,463)

Arginine deminase derived from mycoplasma arthritidis and polymer conjugates containing the same (United States Patent 5,804,183)

Mycoplasma arthritidis superantigen (United States Patent 5,795,974)

DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures (United States Patent 5,788,962)

Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same (United States Patent 5,766,594)

PCR-based assay for Mycoplasma hyopneumoniae (United States Patent 5,712,090)

Mycoplasma polymerase chain reaction testing system using a set of mixed and single sequence primers (United States Patent 5,693,467)

Nucleic acid probes and method for detecting Mycoplasma pneumoniae (United States Patent 5,691,149)

Mycoplasmas-agents for detecting and characterizing mycoplasmas in vitro (United States Patent 5,688,646)

Mycoplasmas--agents for detecting and characterizing mycoplasmas in vitro (United States Patent 5,677,123)

Nucleic acid hybridization assay probes, helper probes and amplification oligonucleotides targeted to Mycoplasma pneumoniae nucleic acid (United States Patent 5,656,427)

Monoclonal antibodies against Mycoplasma pneumoniae, hybridomas producing these, methods for the preparation thereof, and the use thereof (United States Patent 5,641,638)

Mycoplasma arthritidis T-cell mitogen (United States Patent 5,639,869)

Poultry Mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same (United States Patent 5,621,076)

Fluorometric quantitation of mycoplasmas (United States Patent 5,604,096)

Detection and prevention of mycoplasma hominis infection (United States Patent 5,595,871)

Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof (United States Patent 5,565,205)

Nucleic acid probes for the detection of mycoplasma pneumoniae and mycoplasma genitalium (United States Patent 5,552,279)

Adherent and invasive mycoplasma (United States Patent 5,534,413)

Mycoplasma diagnostic assay (United States Patent 5,532,134)

Diagnostic kit and diagnostic method for mycoplasma utilizing carbohydrate receptors (United States Patent 5,529,904)

Antibiotic compounds and methods to treat gram-positive bacterial and mycoplasmal infections (United States Patent 5,516,905)

Polynucleotide amplification mycoplasma assay, primers, and kits therefore (United States Patent 5,491,062)

Poultry mycoplasma antigen, gene thereof and recombinant vectors containing the gene as well as vaccines utilizing the same (United States Patent 5,489,430)

Arginine deiminase from a Mycoplasma arginini strain (United States Patent 5,474,928)

DNA encoding 85kd polypeptide useful in diagnosis of Mycoplasma infections in animals (United States Patent 5,459,048)

Gene encoding cytadhesin protein of mycoplasma gallisepticum and its use (United States Patent 5,378,820)

Method for detection of mycoplasma (United States Patent 5,376,525)

Method for mycoplasma detection in a biological sample (United States Patent 5,369,005)

Thimerosal inactivated mycoplasma hyopneumoniae vaccine (United States Patent 5,338,543)

Administering particular compounds against various parasites, mycoplasmas, other indications and other infections (United States Patent 5,292,725)

Methods and compositions for production of mycoplasmal adhesins (United States Patent 5,281,694)

Mycoplasma hyopneumoniae antigen and uses therefor (United States Patent 5,252,328)

Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen (United States Patent 5,242,823)

Pathogenic mycoplasma (United States Patent 5,242,820)

Intranasal administration of Mycoplasma hyopneumoniae antigen (United States Patent 5,240,706)

Adherent and invasive mycoplasma (United States Patent 5,215,914)

Method of detecting mycoplasma infection in poultry and compositions therefor (United States Patent 5,196,514)

Diagnostic methods for mycoplasma genitalium infections (United States Patent 5,158,870)

Method of preventing mycoplasma infection (United States Patent 5,104,901)

Adhesion of Mycoplasma pneumoniae and Mycoplasma hominus to sulfatide (United States Patent 5,089,479)

Method for the purification of a 168 kD protein from mycoplasma pneumoniae (United States Patent 5,084,561)

Assay for Mycoplasma fermentans (United States Patent 5,073,486)

Mycoplasma vaccine (United States Patent 5,064,647)

Prevention or elimination of mycoplasma contamination of animal or plant cell cultures (United States Patent 5,051,419)

Methods and compositions for production of mycoplasmal adhesins (United States Patent 5,026,636)

Anti-mycoplasma agent (United States Patent 4,950,686)

Monoclonal antibodies for Mycoplasma pneumoniae and use for diagnosis of pneumonia (United States Patent 4,945,041)

Method for decontamination of mycoplasma-infected cell cultures (United States Patent 4,895,803)

DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins (United States Patent 4,894,332)

Rapid detection of mycoplasmas (United States Patent 4,855,227)

Triphasic mycoplasmatales culture device (United States Patent 4,721,678)

Specific mycoplasma membrane antigen and antibody and their clinical applications (United States Patent 4,666,851)

Triphasic mycoplasmatales detection method (United States Patent 4,598,045)

Methods of controlling mycoplasma infections (United States Patent 4,594,337)

Detection of mycoplasma infection in cell cultures (United States Patent 4,387,161)

Method of using dialkylphenols in the treatment of mycoplasma diseases (United States Patent 4,192,896)

Method for the control of Mycoplasma hyopneumoniae in swine with alkylated BM123.gamma. type antibiotics (United States Patent 4,170,646)

Use of chlorhydroxyquinoline to inhibit growth of mycoplasmas (United States Patent 4,166,118)

Prevention and treatment of mycoplasma-associated diseases (United States Patent 7,108,851)

Antigen composition against mycoplasma (United States Patent 7,074,894)

Mycoplasma hyopneumoniae vaccine and methods for reducing Mycoplasma bovis pneumonia in cattle (United States Patent 7,056,492)

Mycoplasma hyopneumoniae bacterin vaccine (United States Patent 7,018,638)

One dose vaccination with Mycoplasma hyopneumoniae (United States Patent 6,846,477)

Detection of Mycoplasma in patients with chronic fatigue syndrome and related disorders (United States Patent 6,815,161)

Method for the preservation of viruses and mycoplasma (United States Patent 6,664,099)

Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae (United States Patent 6,585,981)

Multivalent Mycoplasma bacterin (United States Patent 6,548,069)

Nucleotide sequence of the mycoplasma genitalium genome, fragments thereof, and uses thereof (United States Patent 6,537,773)

Polynucleotides encoding a mycoplasma protein involved in cell growth regulation (United States Patent 6,506,892)

Detection of Mycoplasma genus and species in patients with chronic fatigue syndrome and fibromyalgia (United States Patent 6,492,113)

Nucleic acid probes for the detection of genital mycoplasmas (United States Patent 6,482,589)

Compositions comprising equisetum and symphytum and methods for the treatment of symptoms associated with mycoplasma infection (United States Patent 6,416,792)

Amplification and detection of mycoplasma pneumoniae targeting the ORF9 region of the hmw gene cluster (United States Patent 6,399,309)

Glycoglycerophospholipid, antibody thereagainst, and method for detecting mycoplasma (United States Patent 6,376,203)

Amplification and detection of mycoplasma pneumoniae targeting the P1 gene (United States Patent 6,277,582)

Mycoplasma recombinant polypeptides and vaccines (United States Patent 6,171,589)

Recombinant mycoplasma hyopneumoniae vaccine (United States Patent 6,162,435)

Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same (United States Patent 6,132,713)

Primers and probes for the amplification, detection and typing of Mycoplasma pneumoniae (United States Patent 6,110,681)

Non-virulent Mycoplasma synoviae and vaccine thereof (United States Patent 6,001,348)

Although his recognition as a registered patent agent permits him to represent others in all patent matters before the United States Patent and Trademark Office, Dr. Demchick limits his practice to patent matters involving inventions for which he is confident that his expertise will allow him to serve his client well. He will gladly discuss whether he is comfortable handling cases involving inventions in a particular field. He will err on the side of declining cases if he has uncertainty about his ability to do what is needed in the case. Dr. Demchick does not represent clients in court. However, he refers clients to a patent attorney who does represent others in court, if it appears likely that patent related representation in court is appropriate. Dr. Demchick prepares and files non-provisional (regular) patent applications and provisional patent applications. He prepares and files utility patent applications and design patent applications. He prepares and files U.S. patent applications and international patent applications under the Patent Cooperation Treaty (PCT). He prepares and files applications to enter the U.S. National Phase for inventions for which international patent applications (PCT) were already filed. One of the matters he discusses with each client or potential client is which type of application(s) best meets that client's needs. He usually does a patent search (patentability search) as part of the preparation of a patent application. He discusses the value of patent searching with each inventor before agreeing to prepare a patent application for that inventor.